FDAnews
www.fdanews.com/articles/72369-teva-to-acquire-china-pharma-company-in-full

Teva to Acquire China Pharma Company in Full

May 17, 2005

Teva Pharmaceutical Industries currently has specialized biogeneric R&D centers in Lithuania, Mexico and China, as well as a recently established development team in Israel. Most of these centers are fully owned, including branches of U.S. company Sicor, acquired by Teva last year. The story with Teva's Chinese biogenerics development center is different. Teva owns only 45 percent of Tianjin Hualida Biotechnology Pharmaceutical, while one of China's largest pharmaceutical companies, Tianjin Pharmaceutical Holdings Ltd., owns the other 55 percent.

Big News Network

(http://feeds.bignewsnetwork.com/redir.php?jid=419075af95850dd1&cat=6dcd932030878143)